HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies
about
HIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchDeveloping Combined HIV Vaccine Strategies for a Functional CureBiocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccinesThe presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort studyChallenges in HIV Vaccine Research for Treatment and Prevention.Novel biopanning strategy to identify epitopes associated with vaccine protection.HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation.Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trialAssociation between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohortHIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.Live-virus exposure of vaccine-protected macaques alters the anti-HIV-1 antibody repertoire in the absence of viremia.HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trialA HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice.Impact of antibody quality and anamnestic response on viremia control post-challenge in a combined Tat/Env vaccine regimen in rhesus macaques.Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses.Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine.Beyond RGD: virus interactions with integrins.Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells.The V1/V2 loop of HIV-1 gp120 is necessary for Tat binding and consequent modulation of virus entry.Predicting Protein-Protein Interactions Using BiGGER: Case Studies."cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies".
P2860
Q26746070-810E8A04-A597-4B29-AC1C-0666FA179508Q26998898-DE5F4B57-9436-4BC5-81E1-3E9A01F0E1E4Q27333734-3EDD2C83-4B4A-4E49-8649-A5D564F3EE63Q33864926-7483B275-0D0A-4F92-95A4-7C71D49C138BQ34148683-BA4CAC17-A1A6-4451-94D6-C49E7AB1D196Q34579037-F84A1E79-0875-465E-9E29-227D1537389BQ35000687-771BF347-1D1A-43C0-AC01-64C84AC2B3CCQ35156935-B31D3BB9-33F2-4523-9D0F-8BC3264319F1Q35552889-5256982E-5952-446D-A44A-74220800F81DQ36083803-1986BBEA-01C0-44C7-BD7D-F85CCF63019EQ36109585-7CC05273-1D26-48A0-B53C-14E368B98679Q36964284-4BF8C2FB-D62F-4F95-9115-88CACEE255CEQ36986644-D5D26656-0891-414A-881F-EFC4F5F3E1AFQ37054470-66FA3D90-51DC-40A9-A6A3-A3E8233B5242Q37096865-B80FCCFB-3AFB-4CE6-B57E-CF2EBD4B670BQ37419985-6C9F75F2-B435-428C-AAAF-2ABA42F7E475Q38533881-1C5F10F8-0ED2-4657-8B30-8303EA16309CQ38576959-DF36DEEB-6D6B-43D4-8D8D-CF3B01FC0769Q39039132-949FF24A-3528-4C7B-83DC-D3B4CEA63F3EQ39115158-604BEF55-A8D1-42E8-BD61-A2D42605B447Q39495816-5A800888-7775-443C-A885-EA5DC17A7B23Q46698274-C8CFC129-D295-40EF-A6C3-DBFD839D0C29
P2860
HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
HIV-1 tat promotes integrin-me ...... ization by anti-HIV antibodies
@ast
HIV-1 tat promotes integrin-me ...... ization by anti-HIV antibodies
@en
HIV-1 tat promotes integrin-me ...... ization by anti-HIV antibodies
@nl
type
label
HIV-1 tat promotes integrin-me ...... ization by anti-HIV antibodies
@ast
HIV-1 tat promotes integrin-me ...... ization by anti-HIV antibodies
@en
HIV-1 tat promotes integrin-me ...... ization by anti-HIV antibodies
@nl
prefLabel
HIV-1 tat promotes integrin-me ...... ization by anti-HIV antibodies
@ast
HIV-1 tat promotes integrin-me ...... ization by anti-HIV antibodies
@en
HIV-1 tat promotes integrin-me ...... ization by anti-HIV antibodies
@nl
P2093
P2860
P50
P1433
P1476
HIV-1 tat promotes integrin-me ...... ization by anti-HIV antibodies
@en
P2093
Alessandra Borsetti
Antonella Tripiciano
Aurelio Cafaro
Barbara Collacchi
Chiara Chiozzini
Elaine Kan
Elena Toschi
Emanuele Fanales-Belasio
Enrico Garaci
Fausto Titti
P2860
P304
P356
10.1371/JOURNAL.PONE.0048781
P407
P50
P577
2012-11-13T00:00:00Z